MENU
+Compare
RDHL
Stock ticker: NASDAQ
AS OF
Apr 3, 01:05 PM (EDT)
Price
$2.26
Change
-$0.19 (-7.76%)
Capitalization
15.74M

RDHL Redhill Biopharma Ltd Forecast, Technical & Fundamental Analysis

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases... Show more

Industry: #Biotechnology
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RDHL with price predictions
Apr 02, 2025

RDHL's RSI Oscillator remains in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for RDHL just turned positive on March 18, 2025. Looking at past instances where RDHL's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDHL advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RDHL as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDHL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RDHL entered a downward trend on March 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.706) is normal, around the industry mean (60.901). P/E Ratio (0.000) is within average values for comparable stocks, (90.174). RDHL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.038) is also within normal values, averaging (20.092).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RDHL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RDHL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a company which engages in acquisition and development of patented formulations

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
21 Ha’arba’a Street
Phone
+972 35413131
Employees
113
Web
https://www.redhillbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR6.480.30
+4.85%
Vir Biotechnology
CCL20.020.63
+3.25%
Carnival Corp
COCP1.430.01
+0.70%
Cocrystal Pharma
PGNY22.98-0.11
-0.48%
Progyny
EOSE3.99-0.02
-0.50%
Eos Energy Enterprises

RDHL and Stocks

Correlation & Price change

A.I.dvisor tells us that RDHL and EOLS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDHL and EOLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDHL
1D Price
Change %
RDHL100%
-3.92%
EOLS - RDHL
30%
Poorly correlated
+1.92%
ACET - RDHL
27%
Poorly correlated
-1.50%
PTPI - RDHL
26%
Poorly correlated
-14.29%
SNOA - RDHL
23%
Poorly correlated
-0.46%
DVAX - RDHL
23%
Poorly correlated
+1.26%
More